XML 101 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
Intangible Assets, Net (Tables)
 12 Months Ended
Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets, net, consist of the following:
December 28,
2024		December 30,
2023
(in millions)Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount		Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount
Intangible assets subject to amortization:
Customer relationships$199.3 $(41.7)$157.6 $209.2 $(31.5)$177.7 
Acquired technologies164.9 (62.0)102.9 174.7 (45.3)129.4 
Capitalized software development costs(1)
54.1 (28.6)25.5 53.9 (15.2)38.7 
Licenses30.3 (6.2)24.1 39.7 (7.4)32.3 
Patents(1)
44.0 (17.5)26.5 39.2 (15.2)24.0 
Trademarks20.1 (9.0)11.1 20.1 (7.4)12.7 
Licenses-related party(1)
7.5 (7.1)0.4 7.5 (6.7)0.8 
Non-compete agreements6.3 (4.1)2.2 6.3 (2.6)3.7 
Other1.6 (1.0)0.6 1.7 (1.1)0.6 
     Total intangible assets subject to amortization, net$528.1 $(177.2)$350.9 $552.3 $(132.4)$419.9 
Intangible assets not subject to amortization:
Trademarks$217.3 $242.4 
Impairment charge(10.0)(10.0)
     Total trademarks207.3 232.4 
     Intangible assets, net$558.2 $652.3 
______________
(1)    During the fourth quarter of 2024, in connection with the Company’s strategic realignment initiative, the Company’s healthcare segment recorded a charge of $26.0 million for a reduction in capitalized software development costs, patents and licenses-related party that are being phased out and/or no longer supported, which was recorded to selling, general and administrative expenses. The Company also terminated the professional services agreements associated with LML and Vantrix.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated amortization expense for each of the next fiscal years is as follows:
Fiscal year
Amount
(in millions)
2025$51.6 
202650.3 
202738.0 
202837.6 
202937.2 
Thereafter136.2 
Total$350.9